The Current Ratio as of November 2024 (TTM) for Theriva Biologics, Inc. (TOVX) is 2.88

According to Theriva Biologics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.88. This represents a change of -20.72% compared to the average of 3.63 of the last 4 quarters.

Theriva Biologics, Inc. (TOVX) Historical Current Ratio (quarterly & annually)

How has TOVX Current Ratio performed in the past?

The mean historical Current Ratio of Theriva Biologics, Inc. over the last ten years is 5.13. The current 2.88 Current Ratio has changed 5.52% with respect to the historical average. Over the past ten years (40 quarters), TOVX's Current Ratio was at its highest in in the March 2021 quarter at 37.06. The Current Ratio was at its lowest in in the June 2015 quarter at 0.46.

Theriva Biologics, Inc. (TOVX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Theriva Biologics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theriva Biologics, Inc. (TOVX) Average Current Ratio

How has TOVX Current Ratio performed in the past?

The current Current Ratio of Theriva Biologics, Inc. (TOVX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theriva Biologics, Inc. (TOVX) Current Ratio vs. Peers

How is TOVX’s Current Ratio compared to its peers?

Theriva Biologics, Inc.’s Current Ratio is less than Lumos Pharma, Inc. (4.23), less than Diffusion Pharmaceuticals Inc. (10.96), greater than Avalo Therapeutics, Inc. (0.99), greater than Catalyst Biosciences, Inc. (0), greater than Panbela Therapeutics, Inc. (0.05), greater than Virpax Pharmaceuticals, Inc. (0.48), greater than Revelation Biosciences, Inc. (1.10), greater than Biodexa Pharmaceuticals Plc (2.16), less than Praxis Precision Medicines, Inc. (17.30), greater than First Wave BioPharma, Inc. (1.21), less than Salarius Pharmaceuticals, Inc. (2.98), less than SAB Biotherapeutics, Inc. (5.24), greater than Vaccinex, Inc. (0.42), greater than GeoVax Labs, Inc. (0.60), greater than Kintara Therapeutics, Inc. (2.45), less than Fresh Tracks Therapeutics, Inc. (6.98), less than Lisata Therapeutics, Inc. (9.42), less than Marker Therapeutics, Inc. (5.92), greater than Exicure, Inc. (0.61), greater than Protagenic Therapeutics, Inc. (2.03), less than PMV Pharmaceuticals, Inc. (19.22),

Build a custom stock screener for Theriva Biologics, Inc. (TOVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theriva Biologics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theriva Biologics, Inc. (TOVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theriva Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.